Stereotactic radiosurgery for non-vestibular cranial nerve schwanommas
- 167 Downloads
Non-vestibular cranial nerve schwannomas (NVCNS) are rare lesions, representing <10 % of cranial nerve schwannomas. The optimal treatment for NVCNS is often derived from vestibular schwannomas experience. Surgical resection has been referred to as the first line treatment for those benign tumors, but significant complication rates are reported. Stereotactic radiosurgery (SRS) has arisen as a mainstay of treatment for many benign tumors, including schwanommas. We retrospectively reviewed the outcomes of NVCNS treated by SRS to characterize tumor control, symptom relief, toxicity, and the role of hypo-fractionation of SRS dose. Eighty-eight (88) patients, with ninety-five (95) NVCNS were treated with either single or multi-session SRS from 2001 to 2014. Local control was achieved in 94 % of patients treated (median follow-up of 33 months, range 1–155). Complications were seen in 7.4 % of cases treated with SRS. At 1-year, 57 % of patients had improvement or resolution of their symptoms, while 35 % were stable and 8 % had worsening or increased symptoms. While 42 % received only one session, results on local control were similar for one or multiple sessions (p = 0.424). SRS for NVCNS is a treatment modality that provides excellent local control with minimal complication risk compared to traditional neurosurgical techniques. Tumor control obtained with a multi-session treatment was not significantly different from single session treatment. Safety profile was also comparable for uni or multi-session treatments. We concluded that, as seen in VS treated with CK SRS, radiosurgery treatment can be safely delivered in cases of NVCNS.
KeywordsStereotactic radiosurgery Schwannoma Cranial nerve Tumors
Compliance with ethical standards
This study is an institutional board Approved, retrospective review of a prospectively maintained database. We obtained informed consent from all patients included in that study. Dr Scott G Soltys is a consultant for Nektar Therapeutics
Conflict of interest
All the other authors had no conflict of interest direct to declare.
- 4.Woodruff JM, Kourea HP, Louis DN Schwannomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, pp 164–166Google Scholar
- 9.Lunsford LD, Niranjan A, Flickinger JC, Maitz A, Kondziolka D (2014) Radiosurgery of vestibular schwannomas: summary of experience in 829 cases. J Neurosurg 119(Suppl):195–199Google Scholar
- 11.Chang SD, Gibbs IC, Sakamoto GT, Lee E, Oyelese A, Adler JR Jr (2005) Staged stereotactic irradiation for acoustic neuroma. Neurosurgery 56:1254–1261 (Discussion 1261-3)Google Scholar
- 15.Combs SE, Engelhard C, Kopp C, Wiedenmann N, Schramm O, Prokic V, Debus J, Molls M, Grosu A-L (2015) Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas: pooled results from 3 large German centers. Radiother Oncol 114:378–383CrossRefPubMedGoogle Scholar
- 28.Park ES, Lee EJ, Park JB, Cho YH, Hong SH, Kim JH, Kim CJ (2015) A single-institution retrospective study of jugular foramen schwannoma management: radical resection versus subtotal intracranial resection through a retrosigmoid suboccipital approach followed by radiosurgery. World Neurosurg 88:552–562CrossRefPubMedGoogle Scholar
- 30.Hasegawa T, Kato T, Kida Y et al (2016) Gamma Knife surgery for patients with jugular foramen schwannomas: a multiinstitutional retrospective study in Japan. J Neurosurg 125:822–831Google Scholar